Skip to main content
. 2019 Apr 30;20(9):2142. doi: 10.3390/ijms20092142
AATD alpha-1 antitrypsin deficiency
AB apoptotic body
ABCC6 ATP-binding cassette transporter subfamily C member 6
AKT AK strain transforming
ALK1 activin receptor-like kinase 1
ALP alkaline phosphatase
AMP adenosine monophosphate
ANKH progressive ankylosis homolog protein
ApoE apolipoprotein E
ATP adenosine triphosphate
AXL AXL receptor tyrosine kinase
BMP bone morphogenetic protein
Ca calcium
Ca5(PO4)3OH calcium hydroxyapatite
CAD coronary artery disease
CKD chronic kidney disease
CNV choroidal neovascularization
COPD chronic obstructive pulmonary disease
CTC connective tissue calcifying disorder
DES (iso)desmosine
EC endothelial cell
ENPP1 ectonucleotide pyrophosphatase-phosphodiesterase 1
ER endoplasmic reticulum
GACI generalized arterial calcification of infancy
GAS6 growth arrest specific-6
GGCX gamma-glutamyl carboxylase
Gla γ-carboxylated glutamate
Glu glutamate
GRP gla-rich protein
HE hematoxylin-eosin
IHC immunohistochemistry
KS Keutel syndrome
LRP1 lipoprotein receptor-related protein 1
MGP matrix gla protein
MRP6 multi-drug resistance-associated protein 6
OC osteocalcin
OPN osteopontin
OSX osterix
PAD peripheral arterial disease
Pi inorganic phosphate
PIVKA-II protein induced by vitamin K absence or antagonist-II
PO4 phosphate
PPi inorganic pyrophosphate
PXE pseudoxanthoma elasticum
RUNX2 runt-related transcription factor 2
SMAD small body size mothers against decapentaplegic
SNP single nucleotide polymorphism
TGF-β transforming growth factor-β
TLR toll-like receptor
VC vascular calcification
VEGF vascular endothelial growth factor
Vit K vitamin K
VKCFD vitamin K-dependent coagulation factor deficiency
VKDP vitamin K-dependent protein
VKORC1 vitamin K 2,3-epoxide reductase complex subunit 1
VSMC vascular smooth muscle cell
WT wild type